Intertek Prospers In Spite Of Global Trade Slowdown
Intertek may have been one of the better performers among last year’s Tempus Ten - its shares rose 19 per cent - but that has not stopped the FTSE 250 testing and inspection services provide...
Read Full Article
A Complex Family History, Unfolding In Public
In the front courtyard of the Bhutto Naudero House, a mansion filled with mementos of Benazir Bhutto’s legendary father, supporters speculated on the future of the party....
Read Full Article
$49 Fare To Perth As Air War Hots Up
Jetstar increases services on the busy Melbourne to Perth route in a move designed to meet increased demand and combat next month’s launch by Tiger Airways....
Read Full Article
Activists Can Nominate CNet Board, Judge Says
A court in Delaware ruled that a group of investors can nominate seven directors to the board of CNet Networks, one of the original online media companies....
Read Full Article
Music Review | ’La Finta Giardiniera’: Young Mozart, Classically Serious And Silly
The Juilliard Opera Center offered a simple, intelligent production of Mozart’s ludicrously complicated piece on Wednesday at the Peter Jay Sharp Theater....
Read Full Article

Stents News



Profit Jumps at Boston Scientific

Boston Scientific said on Monday that its first-quarter profit more than doubled after it cut expenses to offset declining sales of drug-coated heart stents.
Read Full Article

F.D.A. to Seek More Safety Data on Stents

New federal guidelines recommend that manufacturers track patients receiving stents for up to five years.
Read Full Article

Boston Scientific Loses Patent Trial

A Texas jury has ruled that Boston Scientific’s drug-coated stents infringe a 1997 patent issued to a radiologist and has awarded the inventor $431 million in damages, Boston Scientific said.
Read Full Article

Bypasses Are Best for Multiple Clogged Arteries, Study Says

Bypass surgery remains the best option for heart patients with more than one clogged artery, according to the first big study to compare bypasses with drug-coated stents. In the study, heart attack and death rates were lower among people who had surgery than those given artery-opening balloon angioplasty and stents. It is latest setback for drug-coated stents, which have revolutionized heart care and have been implanted in about six million people worldwide. The study is in Thursday’s New England Journal of Medicine.
Read Full Article

Federal Panel Backs Abbott Heart Stent

Abbott Laboratories moved closer to joining the American market for drug-coated heart stents on Thursday as an advisory panel backed the company’s experimental device.
Read Full Article

External News for: stents

Boston Scientific's WallFlex esophageal stent wins CE Marking, 510(k) clearance - Mass Device

Boston Scientific's WallFlex esophageal stent wins CE Marking, 510(k) clearanceMass Device(BSX) won 510(k) clearance from the US Food and Drug Administration and CE Mark approval for its WallFlex fully covered esophageal stent. The Natick, Mass. ...Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully ...PR Newswire (press release)Boston Scientific Receives FDA's 510 (k)Clearance For WallFlex Fully Covered ...RTT Newsall 21 news articles »

Boston Scientific's WallFlex esophageal stent wins CE Marking, 510(k) clearance - Mass Device

Boston Scientific's WallFlex esophageal stent wins CE Marking, 510(k) clearanceMass Device(BSX) won 510(k) clearance from the US Food and Drug Administration and CE Mark approval for its WallFlex fully covered esophageal stent. The Natick, Mass. ...Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully ...PR Newswire (press release)Boston Scientific Receives FDA's 510 (k)Clearance For WallFlex Fully Covered ...RTT Newsall 21 news articles »

Boston Sci's Promus Element Stents Approved In Europe - Wall Street Journal

Boston Sci's Promus Element Stents Approved In EuropeWall Street Journals (BSX) Promus Element heart stents have been cleared in Europe, giving the company a product it needs there to replace one it will soon lose because of an ...New Boston Scientific stent approved in EuropeThe Associated PressVideo: Boston Scientific Announces European Approval and Launch of Platinum ...ReutersBoston Scientific develops its own stentPress-EnterpriseReuters India -Mass High Tech -RTT Newsall 115 news articles »

Boston Scientific's WallFlex esophageal stent wins CE Marking, 510(k) clearance - Mass Device

Boston Scientific's WallFlex esophageal stent wins CE Marking, 510(k) clearanceMass Device(BSX) won 510(k) clearance from the US Food and Drug Administration and CE Mark approval for its WallFlex fully covered esophageal stent. The Natick, Mass. ...Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully ...PR Newswire (press release)Boston Scientific Receives FDA's 510 (k)Clearance For WallFlex Fully Covered ...RTT Newsall 21 news articles »

Boston Sci's Promus Element Stents Approved In Europe - Wall Street Journal

Boston Sci's Promus Element Stents Approved In EuropeWall Street Journals (BSX) Promus Element heart stents have been cleared in Europe, giving the company a product it needs there to replace one it will soon lose because of an ...New Boston Scientific stent approved in EuropeThe Associated PressVideo: Boston Scientific Announces European Approval and Launch of Platinum ...ReutersBoston Scientific develops its own stentPress-EnterpriseReuters India -Mass High Tech -RTT Newsall 115 news articles »

Reportlinker Adds Drug-Eluting Stents - Global Market Opportunities - PR Newswire (press release)

Reportlinker Adds Drug-Eluting Stents - Global Market OpportunitiesPR Newswire (press release)Increasing acceptance of stents as viable treatment option, expanding patient population seeking drug-eluting stents, and higher reimbursement coverage are ...Broncus Reports Early EASE Trial Results for Airway Bypass With Exhale(R) Drug ...Live-PR.com (press release)all 11 news articles »

 
i8news.com